ACADIA Pharmaceuticals
ACAD
#3510
Rank
NZ$6.80 B
Marketcap
NZ$40.21
Share price
-0.58%
Change (1 day)
21.27%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): NZ$0.47 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are NZ$1.04 Billion. In 2024 the company made an earning of NZ$0.43 Billion, an increase over its 2023 earnings that were of -NZ$85.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.47 B10.85%
2024 NZ$0.43 B-605.67%
2023 -NZ$85.2 Million-76.09%
2022 -NZ$0.36 Billion27.41%
2021 -NZ$0.28 Billion-40.38%
2020 -NZ$0.47 Billion19.88%
2019 -NZ$0.4 Billion-3.92%
2018 -NZ$0.41 Billion-15.04%
2017 -NZ$0.48 Billion6.33%
2016 -NZ$0.46 Billion64.55%
2015 -NZ$0.28 Billion77.47%
2014 -NZ$0.16 Billion143.69%
2013 -NZ$63.35 Million81.93%
2012 -NZ$34.82 Million-8.73%
2011 -NZ$38.15 Million-251.39%
2010 NZ$25.19 M-133.2%
2009 -NZ$75.91 Million-30.82%
2008 -NZ$0.11 Billion6.43%
2007 -NZ$0.11 Billion25.89%
2006 -NZ$81.89 Million36.99%
2005 -NZ$59.78 Million37.22%
2004 -NZ$43.57 Million19.96%
2003 -NZ$36.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.07 B 11,737.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$19.78 B 4,230.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$37.56 B 8,122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.40 B 2,835.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-NZ$0.21 Billion-144.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-NZ$64.49 Million-114.12%๐Ÿ‡บ๐Ÿ‡ธ USA